By Scientia Professor Matthew Colm Kiernan

Journal articles

Henden L; Fearnley LG; Grima N; McCann EP; Dobson-Stone C; Fitzpatrick L; Friend K; Hobson L; Moi Fat SC; Rowe DB; D Silva S; Kwok JB; Halliday GM; Kiernan MC; Mazumder S; Timmins HC; Zoing M; Pamphlett R; Adams L; Bahlo M; Blair IP; Williams KL, 2023, 'Short tandem repeat expansions in sporadic amyotrophic lateral sclerosis and frontotemporal dementia', Science Advances, 9, http://dx.doi.org/10.1126/sciadv.ade2044

Pavey N; Menon P; van den Bos MAJ; Kiernan MC; Vucic S, 2023, 'Cortical inhibition and facilitation are mediated by distinct physiological processes', Neuroscience Letters, 803, http://dx.doi.org/10.1016/j.neulet.2023.137191

Krishnan D; Kiernan MC, 2023, 'Neurotoxic risks from over-the-counter vitamin supplements', Medical Journal of Australia, 218, pp. 304 - 306, http://dx.doi.org/10.5694/mja2.51851

Silsby M; Fois AF; Yiannikas C; Ng K; Kiernan MC; Fung VSC; Vucic S, 2023, 'Chronic inflammatory demyelinating polyradiculoneuropathy-associated tremor: Phenotype and pathogenesis', European Journal of Neurology, 30, pp. 1059 - 1068, http://dx.doi.org/10.1111/ene.15693

Mazumder S; Mccann H; D'silva S; Furlong S; Shepherd CE; Kril JJ; Halliday GM; Rowe DB; Kiernan MC; Tan RH, 2023, 'Riluzole is associated with decreasing neuritic plaque severity in amyotrophic lateral sclerosis', Brain, 146, pp. E17 - E19, http://dx.doi.org/10.1093/brain/awac467

Martinez-Valdes E; Enoka RM; Holobar A; McGill K; Farina D; Besomi M; Hug F; Falla D; Carson RG; Clancy EA; Disselhorst-Klug C; van Dieën JH; Tucker K; Gandevia S; Lowery M; Søgaard K; Besier T; Merletti R; Kiernan MC; Rothwell JC; Perreault E; Hodges PW, 2023, 'Consensus for experimental design in electromyography (CEDE) project: Single motor unit matrix', Journal of Electromyography and Kinesiology, 68, pp. 102726, http://dx.doi.org/10.1016/j.jelekin.2022.102726

Timmins HC; Mizrahi D; Li T; Kiernan MC; Goldstein D; Park SB, 2023, 'Metabolic and lifestyle risk factors for chemotherapy-induced peripheral neuropathy in taxane and platinum-treated patients: a systematic review', Journal of Cancer Survivorship, 17, pp. 222 - 236, http://dx.doi.org/10.1007/s11764-021-00988-x

Li T; Timmins HC; Trinh T; Mizrahi D; Harrison M; Horvath LG; Grimison P; Friedlander M; Kiernan MC; King MT; Rutherford C; Goldstein D; Park SB, 2023, 'Patient-Reported Outcome Measures in Chemotherapy-Induced Peripheral Neurotoxicity: Defining Minimal and Clinically Important Changes', JNCCN Journal of the National Comprehensive Cancer Network, 21, pp. 125 - 132, http://dx.doi.org/10.6004/jnccn.2022.7074

Kutlubaev MA; Caga J; Xu Y; Areprintseva DK; Pervushina EV; Kiernan MC, 2023, 'Apathy in amyotrophic lateral sclerosis: systematic review and meta-analysis of frequency, correlates, and outcomes', Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration, 24, pp. 14 - 23, http://dx.doi.org/10.1080/21678421.2022.2053721

Hannaford A; Byth K; Pavey N; Henderson RD; Mathers S; Needham M; Schultz D; Menon P; Kiernan MC; Vucic S, 2023, 'Clinical and neurophysiological biomarkers of disease progression in amyotrophic lateral sclerosis', Muscle and Nerve, 67, pp. 17 - 24, http://dx.doi.org/10.1002/mus.27736

Moreno-Roco J; Del Valle L; Jiménez D; Acosta I; Castillo JL; Dharmadasa T; Kiernan MC; Matamala JM, 2023, 'Diagnostic utility of transcranial magnetic stimulation for neurodegenerative disease: a critical review', Dementia e Neuropsychologia, 17, http://dx.doi.org/10.1590/1980-5764-DN-2023-0048

Tse NY; Bocchetta M; Todd EG; Devenney EM; Tu S; Caga J; Hodges JR; Halliday GM; Irish M; Kiernan MC; Piguet O; Rohrer JD; Ahmed RM, 2023, 'Distinct hypothalamic involvement in the amyotrophic lateral sclerosis-frontotemporal dementia spectrum', NeuroImage: Clinical, 37, http://dx.doi.org/10.1016/j.nicl.2022.103281

Phan K; He Y; Bhatia S; Pickford R; Mcdonald G; Mazumder S; Timmins HC; Hodges JR; Piguet O; Dzamko N; Halliday GM; Kiernan MC; Kim WS, 2023, 'Multiple pathways of lipid dysregulation in amyotrophic lateral sclerosis', Brain Communications, 5, http://dx.doi.org/10.1093/braincomms/fcac340

Vucic S; Kiernan MC, 2023, 'Nanocrystalline gold (CNM-Au8): a novel bioenergetic treatment for ALS', Expert Opinion on Investigational Drugs, 32, pp. 783 - 785, http://dx.doi.org/10.1080/13543784.2023.2263368

Silsby M; Fois A; Ng K; Yiannikas C; Kiernan M; Fung V; Vucic S, 2023, 'N°51 – Phenotype and pathogenesis of upper limb tremor in CIDP', Clinical Neurophysiology, 150, pp. e88 - e88, http://dx.doi.org/10.1016/j.clinph.2023.03.060

Restuadi R; Steyn FJ; Kabashi E; Ngo ST; Cheng FF; Nabais MF; Thompson MJ; Qi T; Wu Y; Henders AK; Wallace L; Bye CR; Turner BJ; Ziser L; Mathers S; McCombe PA; Needham M; Schultz D; Kiernan MC; van Rheenen W; van den Berg LH; Veldink JH; Ophoff R; Gusev A; Zaitlen N; McRae AF; Henderson RD; Wray NR; Giacomotto J; Garton FC, 2022, 'Functional characterisation of the amyotrophic lateral sclerosis risk locus GPX3/TNIP1', Genome Medicine, 14, http://dx.doi.org/10.1186/s13073-021-01006-6

Willemse SW; Roes KCB; Van Damme P; Hardiman O; Ingre C; Povedano M; Wray NR; Gijzen M; de Pagter MS; Demaegd KC; Janse AFC; Vink RG; Sleutjes BTHM; Chiò A; Corcia P; Reviers E; Al-Chalabi A; Kiernan MC; van den Berg LH; van Es MA; van Eijk RPA, 2022, 'Lithium carbonate in amyotrophic lateral sclerosis patients homozygous for the C-allele at SNP rs12608932 in UNC13A: protocol for a confirmatory, randomized, group-sequential, event-driven, double-blind, placebo-controlled trial', Trials, 23, http://dx.doi.org/10.1186/s13063-022-06906-5

Mazumder S; Kiernan MC; Halliday GM; Timmins HC; Mahoney CJ, 2022, 'The contribution of brain banks to knowledge discovery in amyotrophic lateral sclerosis: A systematic review', Neuropathology and Applied Neurobiology, 48, http://dx.doi.org/10.1111/nan.12845

Caga J; Kiernan MC; Piguet O, 2022, 'A Systematic Review of Caregiver Coping Strategies in Amyotrophic Lateral Sclerosis and Frontotemporal Dementia', Journal of Geriatric Psychiatry and Neurology, 35, pp. 763 - 777, http://dx.doi.org/10.1177/08919887211060016

Li T; Park SB; Battaglini E; King MT; Kiernan MC; Goldstein D; Rutherford C, 2022, 'Assessing chemotherapy-induced peripheral neuropathy with patient reported outcome measures: a systematic review of measurement properties and considerations for future use', Quality of Life Research, 31, pp. 3091 - 3107, http://dx.doi.org/10.1007/s11136-022-03154-7

Park SB; Li T; Kiernan MC; Garg N; Wilson I; White R; Boggild M; McNabb A; Lee-Archer M; Taylor BV, 2022, 'Prevalence of chronic inflammatory demyelinating polyneuropathy and multifocal motor neuropathy in two regions of Australia', Muscle and Nerve, 66, pp. 576 - 582, http://dx.doi.org/10.1002/mus.27698

Noto YI; Kiernan MC, 2022, 'Hyperexcitability and ALS', Journal of Neurology, Neurosurgery and Psychiatry, 93, pp. 1027, http://dx.doi.org/10.1136/jnnp-2021-328756

Kiernan MC, 2022, 'Brainspotting: Adventures in Neurology', Journal of neurology, neurosurgery, and psychiatry, 93, pp. 800 - 801, http://dx.doi.org/10.1136/jnnp-2022-329455

De Oliveira HM; Silsby M; Jaiser SR; Lai HM; Pavey N; Kiernan MC; Williams TL; Vucic S; Baker MR, 2022, 'Electrodiagnostic findings in facial onset sensory motor neuronopathy (FOSMN)', Clinical Neurophysiology, 140, pp. 228 - 238, http://dx.doi.org/10.1016/j.clinph.2022.04.020

Grima N; Henden L; Fearnley LG; Rowe DB; D'Silva S; Pamphlett R; Adams L; Kiernan MC; Mazumder S; Timmins HC; Zoing M; Bahlo M; Blair IP; Williams KL, 2022, 'NEK1 and STMN2 short tandem repeat lengths are not associated with Australian amyotrophic lateral sclerosis risk', Neurobiology of Aging, 116, pp. 92 - 95, http://dx.doi.org/10.1016/j.neurobiolaging.2022.04.012

Tse NY; Tu S; Chen Y; Caga J; Dobson-Stone C; Kwok JB; Halliday GM; Ahmed RM; Hodges JR; Piguet O; Kiernan MC; Devenney EM, 2022, 'Schizotypal traits across the amyotrophic lateral sclerosis–frontotemporal dementia spectrum: pathomechanistic insights', Journal of Neurology, 269, pp. 4241 - 4252, http://dx.doi.org/10.1007/s00415-022-11049-3

Mizrahi D; Goldstein D; Kiernan MC; Robinson L; Pitiyarachchi O; McCullough S; Mendoza-Jones P; Grimison P; Boyle F; Park SB, 2022, 'Development and consensus process for a clinical pathway for the assessment and management of chemotherapy-induced peripheral neuropathy', Supportive Care in Cancer, 30, pp. 5965 - 5974, http://dx.doi.org/10.1007/s00520-022-07024-3

Cornblath DR; Kiernan MC; Kimura J; Koltzenburg M; Lewis RA; Parry GJ; Pollard JD; Sumner AJ, 2022, 'Letter to the Editor re "Complete Foot Drop With Normal Electrodiagnostic Studies: Sunderland 'Zero' Ischemic Conduction Block of the Common Peroneal Nerve" by Peters and Colleagues.', Annals of Plastic Surgery, Publish Ahead of Print, http://dx.doi.org/10.1097/sap.0000000000003245

Gallina A; Disselhorst-Klug C; Farina D; Merletti R; Besomi M; Holobar A; Enoka RM; Hug F; Falla D; Søgaard K; McGill K; Clancy EA; Carson RG; van Dieën JH; Gandevia S; Lowery M; Besier T; Kiernan MC; Rothwell JC; Tucker K; Hodges PW, 2022, 'Consensus for experimental design in electromyography (CEDE) project: High-density surface electromyography matrix', Journal of Electromyography and Kinesiology, 64, pp. 102656, http://dx.doi.org/10.1016/j.jelekin.2022.102656

Katzeff JS; Bright F; Phan K; Kril JJ; Ittner LM; Kassiou M; Hodges JR; Piguet O; Kiernan MC; Halliday GM; Kim WS, 2022, 'Biomarker discovery and development for frontotemporal dementia and amyotrophic lateral sclerosis', Brain, 145, pp. 1598 - 1609, http://dx.doi.org/10.1093/brain/awac077

Goutman SA; Hardiman O; Al-Chalabi A; Chió A; Savelieff MG; Kiernan MC; Feldman EL, 2022, 'Emerging insights into the complex genetics and pathophysiology of amyotrophic lateral sclerosis', The Lancet Neurology, 21, pp. 465 - 479, http://dx.doi.org/10.1016/S1474-4422(21)00414-2

Goutman SA; Hardiman O; Al-Chalabi A; Chió A; Savelieff MG; Kiernan MC; Feldman EL, 2022, 'Recent advances in the diagnosis and prognosis of amyotrophic lateral sclerosis', The Lancet Neurology, 21, pp. 480 - 493, http://dx.doi.org/10.1016/S1474-4422(21)00465-8

Carroll AS; Howells J; Lin CSY; Park SB; Simon N; Reilly MM; Vucic S; Kiernan MC, 2022, 'Differences in nerve excitability properties across upper limb sensory and motor axons', Clinical Neurophysiology, 136, pp. 138 - 149, http://dx.doi.org/10.1016/j.clinph.2021.12.006

Shibuya K; Otani R; Suzuki YI; Kuwabara S; Kiernan MC, 2022, 'Neuronal Hyperexcitability and Free Radical Toxicity in Amyotrophic Lateral Sclerosis: Established and Future Targets', Pharmaceuticals, 15, http://dx.doi.org/10.3390/ph15040433

Timmins HC; Li T; Goldstein D; Trinh T; Mizrahi D; Harrison M; Horvath LG; Friedlander M; Kiernan MC; Park SB, 2022, 'The impact of obesity on neuropathy outcomes for paclitaxel- and oxaliplatin-treated cancer survivors', Journal of Cancer Survivorship, 16, pp. 223 - 232, http://dx.doi.org/10.1007/s11764-021-01012-y

Salmon K; Kiernan MC; Kim SH; Andersen PM; Chio A; Van Den Berg LH; Van Damme P; Al-Chalabi A; Lillo P; Andrews JA; Genge A, 2022, 'The importance of offering early genetic testing in everyone with amyotrophic lateral sclerosis', Brain, 145, pp. 1207 - 1210, http://dx.doi.org/10.1093/brain/awab472

Zhang S; Cooper-Knock J; Weimer AK; Shi M; Moll T; Marshall JNG; Harvey C; Nezhad HG; Franklin J; Souza CDS; Ning K; Wang C; Li J; Dilliott AA; Farhan S; Elhaik E; Pasniceanu I; Livesey MR; Eitan C; Hornstein E; Kenna KP; Blair I; Wray NR; Kiernan M; Mitne Neto M; Chio A; Cauchi R; Robberecht W; van Damme P; Corcia P; Couratier P; Hardiman O; McLaughin R; Gotkine M; Drory V; Ticozzi N; Silani V; Veldink JH; van den Berg LH; de Carvalho M; Mora Pardina JS; Povedano M; Andersen P; Weber M; Başak NA; Al-Chalabi A; Shaw C; Shaw PJ; Morrison KE; Landers JE; Glass JD; Ferraiuolo L; Snyder MP, 2022, 'Genome-wide identification of the genetic basis of amyotrophic lateral sclerosis', Neuron, 110, pp. 992 - 1008.e11, http://dx.doi.org/10.1016/j.neuron.2021.12.019

D'Souza A; Wang C; Tu S; Soligo DJ; Kiernan MC; Barnett M; Calamante F, 2022, 'A robust framework for characterising diffusion metrics of the median and ulnar nerves: Exploiting state-of-the-art tracking methods', Journal of the Peripheral Nervous System, 27, pp. 67 - 83, http://dx.doi.org/10.1111/jns.12478

van Rheenen W; van der Spek RAA; Bakker MK; van Vugt JJFA; Hop PJ; Zwamborn RAJ; de Klein N; Westra HJ; Bakker OB; Deelen P; Shireby G; Hannon E; Moisse M; Baird D; Restuadi R; Dolzhenko E; Dekker AM; Gawor K; Westeneng HJ; Tazelaar GHP; van Eijk KR; Kooyman M; Byrne RP; Doherty M; Heverin M; Al Khleifat A; Iacoangeli A; Shatunov A; Ticozzi N; Cooper-Knock J; Smith BN; Gromicho M; Chandran S; Pal S; Morrison KE; Shaw PJ; Hardy J; Orrell RW; Sendtner M; Meyer T; Başak N; van der Kooi AJ; Ratti A; Fogh I; Gellera C; Lauria G; Corti S; Cereda C; Sproviero D; D’Alfonso S; Sorarù G; Siciliano G; Filosto M; Padovani A; Chiò A; Calvo A; Moglia C; Brunetti M; Canosa A; Grassano M; Beghi E; Pupillo E; Logroscino G; Nefussy B; Osmanovic A; Nordin A; Lerner Y; Zabari M; Gotkine M; Baloh RH; Bell S; Vourc’h P; Corcia P; Couratier P; Millecamps S; Meininger V; Salachas F; Mora Pardina JS; Assialioui A; Rojas-García R; Dion PA; Ross JP; Ludolph AC; Weishaupt JH; Brenner D; Freischmidt A; Bensimon G; Brice A; Durr A; Payan CAM; Saker-Delye S; Wood NW; Topp S; Rademakers R; Tittmann L; Lieb W; Franke A; Ripke S; Braun A; Kraft J, 2022, 'Author Correction: Common and rare variant association analyses in amyotrophic lateral sclerosis identify 15 risk loci with distinct genetic architectures and neuron-specific biology (Nature Genetics, (2021), 53, 12, (1636-1648), 10.1038/s41588-021-00973-1)', Nature Genetics, 54, pp. 361 - 361, http://dx.doi.org/10.1038/s41588-022-01020-3

Bocchetta M; Todd EG; Tse NY; Devenney EM; Tu S; Caga J; Hodges JR; Halliday GM; Irish M; Piguet O; Kiernan MC; Rohrer JD; Ahmed RM, 2022, 'Thalamic and Cerebellar Regional Involvement across the ALS–FTD Spectrum and the Effect of C9orf72', Brain Sciences, 12, http://dx.doi.org/10.3390/brainsci12030336

Hop PJ; Zwamborn RAJ; Hannon E; Shireby GL; Nabais MF; Walker EM; van Rheenen W; van Vugt JJFA; Dekker AM; Westeneng HJ; Tazelaar GHP; van Eijk KR; Moisse M; Baird D; Al Khleifat A; Iacoangeli A; Ticozzi N; Ratti A; Cooper-Knock J; Morrison KE; Shaw PJ; Basak AN; Chiò A; Calvo A; Moglia C; Canosa A; Brunetti M; Grassano M; Gotkine M; Lerner Y; Zabari M; Vourc'H P; Corcia P; Couratier P; Mora Pardina JS; Salas T; Dion P; Ross JP; Henderson RD; Mathers S; McCombe PA; Needham M; Nicholson G; Rowe DB; Pamphlett R; Mather KA; Sachdev PS; Furlong S; Garton FC; Henders AK; Lin T; Ngo ST; Steyn FJ; Wallace L; Williams KL; Neto MM; Cauchi RJ; Blair IP; Kiernan MC; Drory V; Povedano M; de Carvalho M; Pinto S; Weber M; Rouleau GA; Silani V; Landers JE; Shaw CE; Andersen PM; McRae AF; van Es MA; Pasterkamp RJ; Wray NR; McLaughlin RL; Hardiman O; Kenna KP; Tsai E; Runz H; Al-Chalabi A; van den Berg LH; Van Damme P; Mill J; Veldink JH; Heijmans BT; t Hoen PAC; van Meurs J; Jansen R; Franke L; Boomsma DI; Pool R; van Dongen J; Hottenga JJ; van Greevenbroek MMJ; Stehouwer CDA; van der Kallen CJH; Schalkwijk CG; Wijmenga C; Zhernakova S; Tigchelaar EF; Slagboom PE, 2022, 'Genome-wide study of DNA methylation shows alterations in metabolic, inflammatory, and cholesterol pathways in ALS', Science Translational Medicine, 14, http://dx.doi.org/10.1126/scitranslmed.abj0264

Kiernan M; Henderson H, 2022, 'Ocular involvement of acanthosis nigricans.', Orbit, pp. 1, http://dx.doi.org/10.1080/01676830.2021.2014894

Kiernan M; Thaung C; Vahdani K, 2022, 'Mantle cell lymphoma presenting as bilateral upper eyelid entropion.', Orbit, pp. 1, http://dx.doi.org/10.1080/01676830.2022.2025858

Perez-Siles G; Ellis M; Ashe A; Grosz B; Vucic S; Kiernan MC; Morris KA; Reddel SW; Kennerson ML, 2022, 'A Compound Heterozygous Mutation in Calpain 1 Identifies a New Genetic Cause for Spinal Muscular Atrophy Type 4 (SMA4)', Frontiers in Genetics, 12, http://dx.doi.org/10.3389/fgene.2021.801253

Vucic S; Wray N; Henders A; Henderson RD; Talman P; Mathers S; Bellgard M; Aoun S; Birks C; Thomas G; Hansen C; Thomas G; Hogden A; Needham M; Schultz D; Soulis T; Sheean B; Milne J; Rowe D; Zoing M; Kiernan MC, 2022, 'MiNDAUS partnership: a roadmap for the cure and management of motor Neurone disease', Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration, 23, pp. 321 - 328, http://dx.doi.org/10.1080/21678421.2021.1980889

Carroll A; Dyck PJ; de Carvalho M; Kennerson M; Reilly MM; Kiernan MC; Vucic S, 2022, 'Novel approaches to diagnosis and management of hereditary transthyretin amyloidosis', Journal of Neurology, Neurosurgery and Psychiatry, 93, pp. 668 - 678, http://dx.doi.org/10.1136/jnnp-2021-327909

Silsby M; Yiannikas C; Ng K; Kiernan MC; Fung VSC; Vucic S, 2022, 'Posturography as a biomarker of intravenous immunoglobulin efficacy in chronic inflammatory demyelinating polyradiculoneuropathy', Muscle and Nerve, 65, pp. 43 - 50, http://dx.doi.org/10.1002/mus.27398

Ashhurst JF; Tu S; Timmins HC; Kiernan MC, 2022, 'Progress, development, and challenges in amyotrophic lateral sclerosis clinical trials', Expert Review of Neurotherapeutics, 22, pp. 905 - 913, http://dx.doi.org/10.1080/14737175.2022.2161893

Kiernan M, 2022, 'Chandler's Classification or Chandler-Hubert Classification.', Ophthalmic Plast Reconstr Surg, 38, pp. 309, http://dx.doi.org/10.1097/IOP.0000000000002142

Kiernan M, 2022, 'Response to "A rare case of mucoepidermoid carcinoma ex pleomorphic adenoma of the lacrimal gland".', Orbit, 41, pp. 522 - 523, http://dx.doi.org/10.1080/01676830.2022.2042326

Back to profile page